Format

Send to

Choose Destination
J Eur Acad Dermatol Venereol. 2019 Jun 12. doi: 10.1111/jdv.15741. [Epub ahead of print]

Vismodegib resistant mutations are not selected in multifocal relapses of locally advanced basal cell carcinoma after vismodegib discontinuation.

Author information

1
Institute of Skin Research, INSERM U 976, Saint Louis Hospital, Paris, France.
2
Département de Génétique, AP-HP, Hôpital Bichat Claude Bernard, Paris, France.
3
Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
4
Sorbonne Paris Cité, Université Paris-Diderot, Paris, France.
5
Pharmacology-Biologic Laboratory, AP-HP, Saint Louis University Hospital, Paris, France.
6
Department of Dermatology, AP-HP, Hôpital Saint-Louis, Paris, France.
7
Institut Roche, Boulogne-Billancourt, France.
PMID:
31187903
DOI:
10.1111/jdv.15741

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center